Non Follicular Indolent Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Non Follicular Indolent Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma (NCT03364231) | TG Therapeutics, Inc. | 2017-11-30 |
Track Non Follicular Indolent Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.